Next Generation Cellular and Organotypic Assays
After completing her doctorate at the University of Tübingen in 2015, she came to the NMI in 2022 and has been group leader of the Biophotonics & Spectroscopy group ever since. Her research interests include bioimaging using non-destructive, marker-independent microscopy, personalized medicine and in vitro diagnostics, and cell and tissue dynamics (focus on cardiovascular, oncology and immunology).
Selected publications
Marker-independent monitoring of in vitro and in vivo degradation of supramolecular polymers applied in cardiovascular in situ tissue engineering, J Marzi, EC Munnig Schmidt, EM Brauchle, T Wissing, H Bauer, A Serrero, SHM Söntjens, AW Bosman, MAJ Cox, AIPM Smits, K Schenke-Layland; Front. Cardiovasc. Med., 2022, https://doi.org/10.3389/fcvm.2022.885873
Lipidome profiling with Raman microspectroscopy identifies macrophage response to surface topographies of implant materials; N Feuerer, J Marzi, EM Brauchle, DA Carvajal Berrio, F Billing, M Weiss, M Jakobi, N Schneiderhan-Marra, C Shipp, K Schenke-Layland, PNAS, 2021, https://doi.org/10.1073/pnas.2113694118
Raman imaging and Fluorescence Lifetime Imaging Microscopy in Diagnosis of Cancer Stages and Metabolic Monitoring, L Becker, N Janssen, SL Layland, TE Mürdter, AT Nies, K Schenke-Layland, J Marzi; Cancers, 2021, https://doi.org/10.3390/cancers13225682
Non-invasive marker-independent high content analysis of a microphysiological human pancreas-on-a-chip model, A Zbinden, J Marzi, K Schlünder, C Probst, M Urbanczyk, S Black, EM Brauchle, SL Layland, U Kraushaar, G Duffy, K Schenke-Layland, P Loskill; Matrix Biology, 2020, https://doi.org/10.1016/j.matbio.2019.06.008
ORCID: 0000-0003-1545-5430